![](/img/cover-not-exists.png)
Ofatumumab, a fully human anti-CD20 monoclonal antibody, in biological-naive, rheumatoid arthritis patients with an inadequate response to methotrexate: a randomised, double-blind, placebo-controlled clinical trial
Taylor, P. C., Quattrocchi, E., Mallett, S., Kurrasch, R., Petersen, J., Chang, D. J.Volume:
70
Language:
english
Journal:
Annals of the Rheumatic Diseases
DOI:
10.1136/ard.2011.151522
Date:
December, 2011
File:
PDF, 264 KB
english, 2011